These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1812 related items for PubMed ID: 18248570

  • 1. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M.
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [Abstract] [Full Text] [Related]

  • 2. One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy.
    Koelewijn JM, de Haas M, Vrijkotte TG, Bonsel GJ, van der Schoot CE.
    Transfusion; 2008 Aug; 48(8):1721-9. PubMed ID: 18507749
    [Abstract] [Full Text] [Related]

  • 3. Third trimester screening for alloimmunisation in Rhc-negative pregnant women: evaluation of the Dutch national screening programme.
    Slootweg YM, Koelewijn JM, van Kamp IL, van der Bom JG, Oepkes D, de Haas M.
    BJOG; 2016 May; 123(6):955-63. PubMed ID: 26661943
    [Abstract] [Full Text] [Related]

  • 4. Implementation of routine screening for Kell antibodies: does it improve perinatal survival?
    Kamphuis MM, Lindenburg I, van Kamp IL, Meerman RH, Kanhai HH, Oepkes D.
    Transfusion; 2008 May; 48(5):953-7. PubMed ID: 18248569
    [Abstract] [Full Text] [Related]

  • 5. Twin pregnancy complicated by severe hemolytic disease of the fetus and newborn due to anti-g and anti-C.
    Trevett TN, Moise KJ.
    Obstet Gynecol; 2005 Nov; 106(5 Pt 2):1178-80. PubMed ID: 16260562
    [Abstract] [Full Text] [Related]

  • 6. [Hemolytic disease of the newborn and irregular blood group antibodies in the Netherlands: prevalence and morbidity].
    van Dijk BA, Hirasing RA, Overbeeke MA.
    Ned Tijdschr Geneeskd; 1999 Jul 10; 143(28):1465-9. PubMed ID: 10443262
    [Abstract] [Full Text] [Related]

  • 7. Hemolytic disease of newborn due to anti-Jk b in a woman with high risk pregnancy.
    Thakral B, Malhotra S, Saluja K, Kumar P, Marwaha N.
    Transfus Apher Sci; 2010 Aug 10; 43(1):41-3. PubMed ID: 20558106
    [Abstract] [Full Text] [Related]

  • 8. [Significance of alloantibodies other than anti-D hemolytic disease of the fetus and newborn (HDF/N)].
    Lenkiewicz B, Zupańska B.
    Ginekol Pol; 2003 Jan 10; 74(1):48-54. PubMed ID: 12715437
    [Abstract] [Full Text] [Related]

  • 9. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME).
    Dajak S, Stefanović V, Capkun V.
    Transfusion; 2011 Jul 10; 51(7):1380-8. PubMed ID: 21214583
    [Abstract] [Full Text] [Related]

  • 10. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
    Schonewille H, Klumper FJ, van de Watering LM, Kanhai HH, Brand A.
    Am J Obstet Gynecol; 2007 Feb 10; 196(2):143.e1-6. PubMed ID: 17306657
    [Abstract] [Full Text] [Related]

  • 11. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F, Moiz B, Kamran N.
    Transfus Apher Sci; 2015 Feb 10; 52(1):99-102. PubMed ID: 25532481
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility.
    Smith HM, Shirey RS, Thoman SK, Jackson JB.
    Immunohematology; 2013 Feb 10; 29(4):127-30. PubMed ID: 24689681
    [Abstract] [Full Text] [Related]

  • 14. Is antibody screening in Rh (D)-positive pregnant women necessary?
    Lurie S, Eliezer E, Piper I, Woliovitch I.
    J Matern Fetal Neonatal Med; 2003 Dec 10; 14(6):404-6. PubMed ID: 15061320
    [Abstract] [Full Text] [Related]

  • 15. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M, Jadrić H, Karelović D, Roje D, Haspl-Hundrić Z, Hrgović Z, Vućinović Z.
    Z Geburtshilfe Neonatol; 2004 Oct 10; 208(5):197-202. PubMed ID: 15508054
    [Abstract] [Full Text] [Related]

  • 16. Management of isoimmunization in the presence of multiple maternal antibodies.
    Spong CY, Porter AE, Queenan JT.
    Am J Obstet Gynecol; 2001 Aug 10; 185(2):481-4. PubMed ID: 11518913
    [Abstract] [Full Text] [Related]

  • 17. Postnatal outcome in neonates with severe Rhesus c compared to rhesus D hemolytic disease.
    Rath ME, Smits-Wintjens VE, Lindenburg IT, Folman CC, Brand A, van Kamp IL, Oepkes D, Walther FJ, Lopriore E.
    Transfusion; 2013 Jul 10; 53(7):1580-5. PubMed ID: 23113703
    [Abstract] [Full Text] [Related]

  • 18. Fatal hemolytic disease of the fetus and newborn associated with anti-Jr.
    Peyrard T, Pham BN, Arnaud L, Fleutiaux S, Brossard Y, Guerin B, Desmoulins I, Rouger P, Le Pennec PY.
    Transfusion; 2008 Sep 10; 48(9):1906-11. PubMed ID: 18522708
    [Abstract] [Full Text] [Related]

  • 19. Anti-D in Rh positive pregnancies.
    Prasad MR, Krugh D, Rossi KQ, O'Shaughnessy RW.
    Am J Obstet Gynecol; 2006 Oct 10; 195(4):1158-62. PubMed ID: 17000249
    [Abstract] [Full Text] [Related]

  • 20. High anti-HLA response in women exposed to intrauterine transfusions for severe alloimmune hemolytic disease is associated with mother-child HLA triplet mismatches, high anti-D titer, and new red blood cell antibody formation.
    Verduin EP, Schonewille H, Brand A, Haasnoot GW, Claas FH, Lindenburg IT, Lopriore E, Oepkes D, Roelen DL, Doxiadis II.
    Transfusion; 2013 May 10; 53(5):939-47. PubMed ID: 22924899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 91.